4.7 Article

Imaging of polymyalgia rheumatica: indications on its pathogenesis, diagnosis and prognosis

Journal

RHEUMATOLOGY
Volume 51, Issue 1, Pages 77-86

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/keq450

Keywords

polymyalgia rheumatica; imaging; radiography; ultrasound; magnetic resonance imaging; positron emission tomography

Categories

Funding

  1. University of Genova (Fondi Progetti di Ateneo)

Ask authors/readers for more resources

Objectives. Imaging is one of the most appealing techniques to explore PMR, a disease whose causes, development mechanisms and anatomical targets of inflammatory damage are still scarcely known. This review is concerned with an appraisal of PMR with different imaging modalities with a view to highlighting possible clues to its pathogenesis, diagnosis and prognosis. Methods. A systematic literature research was performed searching PubMed until July 2010. The Cochrane Library was searched for the relevant reviews, and the abstracts of the ACR and European League Against Rheumatism congresses of the period 2005-10 were reviewed. Results. A total of 1059 papers were retrieved, 46 of which were selected at the end of the review process; 6 of them were concerned with two different imaging techniques. Of these papers, 6 (11.5%) were concerned with conventional radiology; 8 (15.4%) with scintigraphy; 17 (32.7%) with ultrasonography (US); 15 (28.8%) with MRI; and 6 (11.5%) with PET. MRI, US and PET appeared to be the most promising imaging techniques. Bilateral subacromial bursitis, biceps long head tenosynovitis and trochanteric bursitis were particularly consistent findings. In addition, MRI and PET showed interspinous bursitis and PET frequently showed large-vessel vasculitis. Few papers have addressed the role of imaging for diagnosis, differential diagnosis and prognosis of PMR. Conclusions. Imaging plays an important role in the comprehensive evaluation of PMR, including its pathogenesis, diagnosis and prognosis. Most of its potential is still unexplored, which fact should stimulate further research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Rheumatology

Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica

Dario Camellino, Eric L. Matteson, Frank Buttgereit, Christian Dejaco

NATURE REVIEWS RHEUMATOLOGY (2020)

Review Rheumatology

A seasonal pattern in the onset of polymyalgia rheumatica and giant cell arteritis? A systematic review and meta-analysis

E. Hysa, A. Sobrero, D. Camellino, F. Rumi, G. Carrara, M. Cutolo, C. A. Scire, M. A. Cimmino

SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)

Article Endocrinology & Metabolism

Zoledronate decreases CTLA-4 in vivo and in vitro independently of its action on bone resorption

Andrea Giusti, Dario Camellino, Daniele Saverino, Erika Iervasi, Giuseppe Girasole, Gerolamo Bianchi, Socrates E. Papapoulos

Letter Rheumatology

Reply to: What could a new disease activity score for polymyalgia rheumatica do better?

Dario Camellino, Eric L. Matteson, Frank Buttgereit, Christian Dejaco

NATURE REVIEWS RHEUMATOLOGY (2021)

Review Rheumatology

New insights into the role of imaging in polymyalgia rheumatica

Dario Camellino, Christina Duftner, Christian Dejaco

Summary: PMR is an inflammatory rheumatic disease characterized by pain and stiffness in the neck, shoulder, and pelvic girdles in elderly people. Current research focuses on imaging techniques, particularly FDG-PET/CT, which can help detect underlying GCA in PMR patients with incomplete response to glucocorticoids and/or relapses. These imaging studies provide new insights into the anatomical basis of inflammation in PMR, especially at the hip and spine, aiding in distinguishing the disease from other conditions.

RHEUMATOLOGY (2021)

Article Rheumatology

Blood Biomarkers for Monitoring and Prognosis of Large Vessel Vasculitides

Enrico Tombetti, Elvis Hysa, Justin C. Mason, Marco A. Cimmino, Dario Camellino

Summary: Large vessel vasculitides (LVVs) are inflammatory conditions of large-sized arteries, with early diagnosis and monitoring being crucial. Blood biomarkers play a significant role in disease diagnosis and prognosis definition, but there is currently a lack of accurate and reliable biomarkers identified.

CURRENT RHEUMATOLOGY REPORTS (2021)

Meeting Abstract Rheumatology

EFFECTS OF CHOLECALCIFEROL AND CALCIFEDIOL IN OSTEOPOROTIC WOMEN WITH SECONDARY HYPERPARATHYROIDISM DUE TO SEVERE VITAMIN D DEFICIENCY UNDERGOING ZOLEDRONIC ACID TREATMENT: A RANDOMIZED-CONTROLLED TRIAL

G. Botticella, M. Pizzonia, B. Cossu, R. Bruno, D. Camellino, G. Girasole, A. Giusti, M. Pedrazzoni, S. Alexovits, F. Pleitavino, F. Santolini, A. Nencioni, G. Bianchi

ANNALS OF THE RHEUMATIC DISEASES (2021)

Meeting Abstract Rheumatology

BARICITINIB IN POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS: REPORT OF SIX CASES

D. Camellino, C. Dejaco, A. Giusti, F. Martini, R. Cosso, G. Girasole, G. Bianchi

ANNALS OF THE RHEUMATIC DISEASES (2021)

Meeting Abstract Rheumatology

FDG-PET-DETECTED LARGE VESSEL VASCULITIS DOES NOT PREDICT DISEASE OUTCOME IN PATIENTS WITH GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA

E. Hysa, D. Camellino, C. Bernini, E. Gotelli, S. Paolino, C. Schenone, G. Ferrari, A. Sulli, M. Cutolo, M. A. Cimmino

ANNALS OF THE RHEUMATIC DISEASES (2021)

Meeting Abstract Rheumatology

FINDINGS CONSISTENT WITH SUBCLINICAL VASCULITIS IN PATIENTS WITH NEW ONSET POLYMYALGIA: A SYSTEMATIC LITERATURE REVIEW AND A META-ANALYSIS OF COHORT DATA

D. S. Gozzoli, A. Hemmig, L. Hemkens, L. Werlen, H. Ewald, C. Berger, D. Kyburz, S. Imfeld, M. Aschwanden, M. Stegert, D. Camellino, M. A. Cimmino, C. Campochiaro, A. Tomelleri, L. Henckaerts, D. Blockmans, P. Moya, H. Corominas, R. Buchanan, C. Owen, Y. Van Sleen, E. Brouwer, H. Ymashita, T. Daikeler

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Rheumatology

The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis

N. Ughi, R. Padoan, C. Crotti, S. Sciascia, G. Carrara, A. Zanetti, D. Rozza, S. Monti, D. Camellino, F. Muratore, G. Emmi, L. Quartuccio, S. Morbelli, K. El Aoufy, S. Tonolo, R. Caporali, S. De Vita, C. Salvarani, M. A. Cimmino

Summary: The recommendations have been updated based on new evidence for diagnosing and treating primary large-vessel vasculitis, emphasizing the prompt commencement of high dose oral glucocorticoids to induce clinical remission, and suggesting the use of adjunctive therapy in selected patients.

REUMATISMO (2021)

Review Rheumatology

Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data

Andrea K. Hemmig, Daniele Gozzoli, Laura Werlen, Hannah Ewald, Markus Aschwanden, Daniel Blockmans, Elisabeth Brouwer, Russell R. C. Buchanan, Dario Camellino, Corrado Campochiaro, Marco A. Cimmino, Hector Corominas, Viktoria Gloy, Liesbet Henckaerts, Diego Kyburz, Patricia Moya-Alvarado, Claire E. Owen, Mihaela Stegert, Alessandro Tomelleri, Yannick van Sleen, Hiroyuki Yamashita, Stephan Imfeld, Christoph T. Berger, Lars G. Hemkens, Thomas Daikeler

Summary: The study aimed to determine the prevalence and predictors of subclinical giant cell arteritis in patients with newly diagnosed polymyalgia rheumatica. It found that over a quarter of PMR patients may have subclinical GCA and the prediction model had only modest diagnostic accuracy, suggesting a paradigm shift towards implementing imaging studies in the assessment of PMR patients.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2022)

Review Rheumatology

Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review

Elvis Hysa, Milena Bond, Lisa Ehlers, Dario Camellino, Louise Falzon, Christian Dejaco, Frank Buttgereit, Daniel Aletaha, Andreas Kerschbaumer

Summary: This study provides a systematic review of current evidence on Treat to Target (T2T) strategies in PMR and GCA. It highlights the gaps in knowledge and provides valuable information for developing treatment recommendations.

RHEUMATOLOGY (2023)

Article Rheumatology

Clinical and FDG-PET/CT correlates in patients with polymyalgia rheumatica

D. Camellino, F. Paparo, S. D. Morbelli, G. Pesce, M. Bauckneht, M. Bagnasco, M. Cutolo, G. Sambuceti, M. A. Cimmino

Summary: FDG-PET imaging was used to evaluate joint and vessel uptake in patients with PMR. Patients showed a typical joint pattern, with imaging being the only tool to assess the presence of LVV, as clinical and laboratory findings were insufficient predictors.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2022)

Article Rheumatology

Seasonal onset of polymyalgia rheumatica: correlations with the pattern of clinical presentation, disease severity and outcome in 383 patients from a single centre

A. Sobrero, S. Paolino, E. Hysa, D. Camellino, V. Tomatis, M. Cutolo, M. A. Cimmino

Summary: Polymyalgia rheumatica (PMR) shows no seasonality of onset, except for cases associated with temporal arteritis (TA). This suggests a possible risk factor with seasonal variation in the pathogenesis of PMR.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2021)

No Data Available